Resum
Lucent's New Ventures Group launched 35 ventures out of Bell Laboratories technologies. Notwithstanding this success, NVG has been forced to change its funding approach. It has now evolved into a partnership with private equity capital suppliers called New Venture Partners. This partnership addresses some structural limits upon a public corporation's ability to support internal venture creation over the business cycle, and offers a new model for sustaining corporate innovation.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 16-19 |
Nombre de pàgines | 4 |
Revista | Research Technology Management |
Volum | 46 |
Número | 4 |
DOIs | |
Estat de la publicació | Publicada - 2003 |
Publicat externament | Sí |